chrisvoncsefalvay/vaers-outcomes huggingface dataset:
53 year old male with history of HTN and non-adherence with medications, was NPO when he received his Vaccination. Symptoms of dizzyness reported within 30minutes. Blood Pressure remains essentially unchanged but Ginger ale appeared to ameliorate the dizzyness. Attendee was advised to speak to his PCP asap re: his current elevated Blood Pressure. Declined EMS.
This is a spontaneous report from a contactable RN reported for herself. A 65-years-old female patient received the first dose of PREVNAR 13, via an unspecified route of administration on 05Apr2018 08:00 at single dose in deltoid left for immunisation. Medical history included allergy to sulfa and nitrofurantoin (MACRODANTIN). The patient previously took PNEUMOVAX and influenza vaccine given into bursa both for immunization. The patient's concomitant medications were not reported. The patient experienced still sore 8 days later/she can't put weight on it, or roll over onto it, because it hurts on 05Apr2018 with outcome of recovering, lump over injection site on 09Apr2018 with outcome of unknown, fatigue and a little warm to touch on an unspecified date with outcome of unknown. The patient clarify that she never had a fever, but she was more fatigued. The site never got hot or red, just a little warm to touch. The information on the batch number has been requested.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54-year-old female patient (not pregnant) received BNT162b2 (BNT162B2 NOS), on 25Nov2022 at 18:00 as dose number unknown, single (Batch/Lot number: unknown) at the age of 54 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: The patient was treated with Paxlovid from 17Apr2023 to 21Apr2023. The patient has no known allergies.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300175738 same reporter/patient, different drug/event;
Pain and tenderness at injection site; migraine; mild fever; fatigue; Pain and tenderness at injection site; This is a spontaneous report from a non-contactable consumer or other non hcp (patient herself). A 20-years-old non pregnant female patient received second dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Lot Number: EW0182, Expiry date: Unknown) via an unspecified route of administration, administered in Arm Left on 07May2021 11:45 (at the age of 20-years-old) as dose 2, single for COVID-19 immunisation. Patient was not pregnant at the time of vaccination. The patient medical history and concomitant medications were not reported. Patient previously took BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, lot number: EW0164) administered in Arm Left on 16Apr2021 11:15 am (at the age of 20-years-old) for COVID-19 immunisation. On 07May2021 23:00 the patient experienced pain and tenderness at injection site, migraine, mild fever and fatigue. Patient did not receive the treatment for events. The outcome of events was recovering.  No follow up attempts are possible. No further information is expected.
fever 1 day, headache 3-5 days, back pain 1 cont., abd pain cont, sinus like symptoms cont
Patient reported dark brown coloring in webs of fingers and spot on top of foot. This has occurred about 3 times since getting vaccine- approximately once weekly. No raised bumps or irritation.  the discoloration has come off hands when scrubbed with soap and water, has been more difficult to remove off foot.
No additional AE reported; Caller states a dose that expired on 3/22/2021 was administered to a patient on 3/25/2021; This spontaneous report was received from a medical assistant  referring to a 6-month-old patient of unknown age and gender. The patient's pertinent medical history, concomitant therapies, drug reactions or allergies were not reported.  On 25-MAR-2021, the patient was vaccinated with an expired dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) at a dose of 2 milliliter, orally for prophylaxis  (lot number 1660666 has been verified to be valid, expiration date reported as and validated as 22-MAR-2021) (vaccination scheme and dose number  not reported) (expired product administered). No additional adverse event (AE) reported.
After the pt was vaccinated with the second dose of varicella virus vaccine live a serum VZV antibody test revealed a lack of seroconversion.
About 1 hr after immunization (10:30 am) recipient c/o headache, nausea, shortness of breath.  Tx with Tylenol.  Nausea subsided - other Sx continued.  Taken to Hosp ED Tx with Benadryl - 6-22-09.  6-23-09 All symptoms resolved, recipient with c/o
Patient had 2 doses of Pfizer already and received a dose of the Moderna.  Patient is not having any adverse reactions.
Patient was also administered rocephin 500 mg IM at the same time. Within 5 minutes of receiving both injections, patient began to sneeze continuously and had subsequent runny, stuffy nose. started to c/o feeling like something stuck in his throat. Denied any breathing difficulty. Hives were noted on his arms, face and neck. IM benadryl and Epi-pen administered.  Patient left with EMS
04/26/2021 Vaccination; 11/2021 I noticed achiness and weakness in calf/thigh. Confused thinking and anxiety when really needing to concentrate; cloudy thinking. Achy side muscles, lethargy, fatigue, hard time focusing. The symptoms are still prevalent today. *3/17/2022 Appt with PCM.
Pfizer Covid vaccine was given to 15 year old under EUA which only authorizes 16 year and above for eligibility
swelling  to arm, pain began night of vaccine and has escalated each day, unable to move arm without intense pain, unable to sleep on arm without pain.  Pain radiates into shoulder and down arm to elbow area
No adverse event.  patient was 11 and received Adult vaccine.  Immunization record not available and was also third Hep A vaccine received.
pt recv vax 2APR96 & stomach hurt real bad wed PM face began to swell;t103, dehydration-put pt in hosp;lots of edema behind ears
Very tired; I slept all day the day after receiving shot; The booster made my arm quite achey and tendor for about a week; The booster made my arm quite achey and tendor for about a week; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm, administration date 21Dec2021 (Lot number: FE3594) at the age of 73 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "thyroid function decreased" (ongoing), notes: thyroid function decreased; "mild high cholesterol" (ongoing), notes: mild high cholesterol. Concomitant medication(s) included: LEVOTHYROXIN taken for hypothyroidism (ongoing); ATORVASTATIN taken for blood cholesterol increased (ongoing). Vaccination history included: Bnt162b2 (Dose:1, Anatomical site of injection: arm, route of administration: intramuscular, Batch/lot number: EN6202, Vey tired), administration date: 27Feb2021, when the patient was 72 years old, for COVID-19 Immunization, reaction(s): "Tired", "Dizzy", "Afraid", "Slept all day"; Bnt162b2 (Dose:2, Anatomical site of injection: arm, route of administration: intramuscular, Batch/lot number:ER2613, Slept all day), administration date: 20Mar2021, when the patient was 72 years old, for COVID-19 Immunization, reaction(s): "Slept all day", "Tired". The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "Very tired"; FATIGUE (non-serious) with onset 22Dec2021, outcome "unknown", described as "I slept all day the day after receiving shot"; PAIN IN EXTREMITY (non-serious), TENDERNESS (non-serious), outcome "recovered" and all described as "The booster made my arm quite achey and tendor for about a week". No follow-up attempts are possible. No further information is expected.
My ears hurt as though I had an ear infection and burned inside and out. Seemed to resolve itself about 24 hours later.
This case was reported by a consumer via call center representative and described the occurrence of pain in a adult female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced pain, pain in arm and lethargy. The patient was treated with TYLENOL. On an unknown date, the outcome of the pain, pain in arm and lethargy were recovered/resolved. It was unknown if the reporter considered the pain, pain in arm and lethargy to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient felt achy, had a sore arm, and was lethargic after receiving the SHINGRIX vaccine. She took TYLENOL and went to bed to sleep it off. The events aches, soreness, and lethargy resolved within six hours. Limited information was reported, the reporter did not wish to complete the safety report and hence a follow up was discouraged. The reporter also stated that, she did not complain about the SHINGRIX and was very happy with her experience with the SHINGRIX vaccine. For tolerance after 2nd dose of SHINGRIX, refer US2018GSK144911.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 014M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Feb-2021 at 9:02 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Mar-2021 at 9:06 AM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 53.18 and 53.10.  Concomitant products were not provided.  On 11-Jan-2021, Excursion time was 09 AM and 10 AM, temperature was 35, total doses given for the day was 195, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 23-Mar-2021, vial was moved to clinic on 27-Mar-2021. 20 vials were sent to clinic. Vaccine BUD date was 22-Apr-2021. Excursion time was 09 AM, 11 AM, 12 PM, 1 PM, 2 PM, 3 PM, 4 PM, 5 PM temperature was 33, 34, 35, total doses given for the day was 199, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 24-Feb-2021, vial was moved to clinic on 27-Feb-2021. 20 vials were sent to clinic. Vaccine BUD date was 26-Mar-2021.   On 31-Mar-2021, vials were stored in cooler 1, at following time and temperature respectively, 9 AM: 33, 10 AM: 36, 11 AM: 35, 12 AM: 35, 1PM: 35, 2 PM: 35, 3 PM: 34, 4 PM: 34 and 5 PM: 35.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
I was looking through the vaccinated list and there was an individual who received a 3rd dose of Moderna on 7/31.  This individual did list ?No? to the question of if this was their first vaccine dose when they registered on-site.
At 09:30 AM on 10/14/2022 patient received two vaccines PFIZER BIVALENT in Left Deltoid and HI-DOSE Seasonal Influenza FLU-AD in Right Deltoid.  Waited in the clinic for 15 minutes before being released.  Later that same day the patient experienced chest pain.  After several hours of pain unresolved, she went to a local ED.  The HCF kept patient overnight for 2 nights running a series of test.  The patient was released on Sunday 10/16/2022 in good health.
Patient presented with a red rash on her right arm spreading downward toward her elbow. The affected area was warm but soft and unresponsive to topical diphenhydramine.
7 cm swelling with 5cm induration/swelling tx with antibiotic KEFLEX.
Started Left upper arm cellulitis = started on KEFLEX on 09/07. Now has cellulitis on left lower arm = antibiotic changed to BACTRIM 09/11 to cover possible MRSA. The reaction could possibly be due to a bug bite (incidental).
Information has been received from a 29 yr old female with no allergies or medical history who on 23Aug04 was vaccinated with two 0.5ml doses of varicella virus vaccine live at the same time. There was no concomitant therapy. The pt reported that on 06Sep04, two weeks after being vaccinated, she developed chickenpox. Unspecified medical attention was sought, but no lab/diagnostic tests were performed. At the time of this report, the outcome was unk. Additional information has been requested.
34 yo male patient who is an employee at this institution. He is s/p full Moderna vaccination: first dose 12/30/20, second dose 2/9/2021. Underwent voluntary COVID-19 testing on 7/19 after experiencing fatigue, congestion/runny nose. Does not report exposure to any COVID positive persons. POCT rapid test resulted positive for COVID-19.
Dizziness, Headache, Lightheadedness; Injection site pain Narrative:  Dizzy and lightheaded 14 minutes after injection. Headache and injection site pain for 2 days after injection.
Hives, Rash, itchy/burning sensation, throat tighten, hot/sweaty
Employee received the 2nd dose of Rubeola (measles) vaccine (5 weeks and 3 days after the 1st dose was given without severe reaction) and noted itching and redness at site, approx. 5 1/2 hours, post vax, experienced tiredness and 5 1/2cm by 4 cm area of redness under right upper arm and raised with area pruritic with some tenderness. Denies other adverse reaction or feeling of respiratory alterations. Employee to be seen by FNP today for evaluation. Employee had not taken any antihistamines up the present. Benadryl 25mg every 4-6 hours for itching.
pt recv vax 5MAR saturday AM child woke w/h/a, swollen parotid glands, fever, diff swallowing;vomited x 1;no rash;sick through 9MAR today fever dec easier swallowing & less neck swelling;
Within 1 hour of injection pt has had pain at/around injection site and radiates down the arm. It's constant pain and occasionally decreases range of motion to where cannot raise above shoulder. Has tried: TYLENOL, Ibuprofen, VICODIN, Aspercreme, Icy Hot, Activon, heating pad, with no relief.
Mild right sided Bell's Palsy 10 days after 2nd Moderna  vaccine. My daughter recently got Bell's palsy 2 months after her 2nd dose of Pfizer vaccine. She also submitted a VAERS report  Might the Bell's palsy be a reaction to the vaccine? Might there be a genetic predisposition since my daughter and I now have Bell's palsy.
I received the vaccine in my left arm. At first I just had a sore arm for a day after my vaccine. On day 8 (April 9)  I developed a rash at my injection site which lasted 4 days. After that I still felt weird on my left side?random pains only on my left side and some muscle weakness  and soreness in my left arm. On April 22 I broke out in a very painful rash near my groin on the left side (same side as my vaccine injection). On April 25 I was diagnosed with shingles .
This spontaneous report as received from a nurse. On an unknown date, unspecified number of patients received improperly stored GARDASIL. No adverse effects reported. Additional information is not expected.
Information has been received from a registered nurse concerning a 62 day old female patient with no pertinent medical history and no known drug allergies who on 26-JAN-2009 was vaccinated with a dose of ROTATEQ (lot# 661033/0894X) orally, and spit up her dose. There was no concomitant medication. Patient was at the office and no lab diagnostic studies were performed. The nurse thinks the child spit up because she was fed right before receiving ROTATEQ and does not think that ROTATEQ caused her to spit up. Additional information has been requested.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Exhaustion / Lethargy-Mild, Systemic: Nausea-Mild, Systemic: Vomiting-Mild, Additional Details: Patient felt nauseous and vomited so I called 911 and patient was picked up by ambulance
Low-grade fever, chills, fatigue, shortness of breath, restless leg syndrome-like symptoms (neurological), headache, nauseousness, body aches, insomnia, brain fog
10 MINUTES ARE ADMINISTERED DOSE PATIENT LOSS SIGHT, EXPERIENCED PITCH NOISE, FELT FATIGUED AND HEART RACING--IMMEDIATELY WE PUT PATIENT IN SUPINE POSITION--RAISED LEGS WITH COLD COMPRESSED. CHECKED VITALS WITH FINGER MONITORING AND O2 STATS, HEART RATE NORMAL. HE BAGAN TO FEEL BETTER--HE REPORTED WAS ANXIOUS ABOUT VACCINE. KEPT FOR 10 MIN MORE MONITORING. PATIENT PARENTS WILL MONITOR AND ADVISED S/S TO LOOK OUT FOR IF NEED TO GO ER.  DID NOT CALL AMBULANCE DUE TO NO ANAPHYLATIC SHOT--EPIPEN WAS NOT USED.
Pain at the injection site; Nose bleeding; A spontaneous report was received from a (Consumer) concerning an unknown age, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced pain at the injection site and Nose bleeding.  The patient's medical history was not included. No relevant concomitant medications were reported.    On 13 Feb 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) unknown route and site for prophylaxis of COVID-19 infection.  On 13 Feb 2021, the patient experienced Pain at the injection site and nose bleeding. Laboratory details not provided. Treatment details not included. Action taken with mRNA-1273 in response to the events was not reported.  At the time of this report, the outcome of the events were unknown.
Patient received vaccination and less than 5 minutes after vaccination patient began to not feel well. Patient's significant other came to get me and when we got to patient he was pale and not feeling well. Patient then fainted and lost consciousness but did not fall out of his chair. We were able to keep him upright so he would not hit his head. Patient had pulse and came to a few moments later. Patient drank some water and was immediately feeling much better after coming out of it. Patient sat for a few more minutes to ensure he was still feeling well then walked about in front of the pharmacy to ensure he still doing well. Patient left about 30 minutes after vaccination. 911 was called but not dispatched as patient refused once he came to.
stiff neck; Very bad headache; Joint aches, especially in neck and shoulder; feeling very tired; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (stiff neck), HEADACHE (Very bad headache), ARTHRALGIA (Joint aches, especially in neck and shoulder) and FATIGUE (feeling very tired) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included VITAMINS NOS for an unknown indication.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 07-Apr-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (stiff neck), HEADACHE (Very bad headache), ARTHRALGIA (Joint aches, especially in neck and shoulder) and FATIGUE (feeling very tired). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, MUSCULOSKELETAL STIFFNESS (stiff neck), HEADACHE (Very bad headache), ARTHRALGIA (Joint aches, especially in neck and shoulder) and FATIGUE (feeling very tired) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable   This case was linked to US-MODERNATX, INC.-MOD-2021-074787 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-074787:Wife case
Information has been received from a physician and a woman at a physician's office concerning a seven year old black male who on 17Aug99 (also reported as 17Aug05) was vaccinated SC with a 0.5mL first dose of varicella virus vaccine live. Concomitant therapy vaccine administered on the same day included a fourth dose of diphtheria toxoid (+) pertussis vaccine (unspecified) (+) tetanus toxoid. About 2 wks prior to the time of this reporting, on 26Oct05, the pt presented to the physician's office with a rash involving 50 lesions, which was reported by the physician to be a small outbreak of breakthrough chicken pox. The adverse event improved and the pt recovered on an unspecified date. There was no product quality complaint reported. Additional information has been requested.
Narrative: 85yo male patient died at home in home hospice care on 9/27/2021. Pt had started home hospice care on 09/23/2021. Pt had suffered a CVA verses seizure disorder seizure which caused a change in status causing the need for full care. Pt had receivec covid vaccines on 5/11/21 & 4/13/21. Likely this death is not related to covid vaccines given patient's age, comorbidities, and long length of time between date of vaccines and date of death.